Bobby L. Boyanton Jr

Professor; Pathologist-in-Chief

University of Arkansas for Medical Sciences

faculty

16 h-index 70 pubs 1,146 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Bobby L. Boyanton Jr.'s research focuses on infectious diseases and public health, with a particular emphasis on pediatric populations and the impact of the SARS-CoV-2 pandemic. His work has investigated the seroprevalence of SARS-CoV-2 in Arkansas children and the effects of non-pharmacologic interventions on respiratory infections. Boyanton has also studied the mitigation strategies for SARS-CoV-2 that have concomitantly reduced infections from other pathogens, including Group A Streptococcus and Methicillin-Resistant Staphylococcus aureus.

His research interests extend to other infectious agents and conditions, such as Histoplasma capsulatum infective endocarditis and locally acquired malaria in Arkansas. Boyanton's publications also touch upon the implementation of pharmacogenomics testing and reviews of pharyngitis pathogens. He has collaborated with Joshua L. Kennedy, Ashton Ingold, Dana Frederick, and Catherine Kirkpatrick at the University of Arkansas for Medical Sciences on multiple publications.

Metrics

  • h-index: 16
  • Publications: 70
  • Citations: 1,146

Selected Publications

  • Photo Quiz: Persistent dysuria and hematuria in a 9-year-old male (2026) DOI
  • Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026) DOI
  • Photo Quiz: A camper with fever, headache, and fatigue (2026) DOI
  • From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma (2025) DOI
  • Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study (2025) DOI
  • Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps (2024) DOI
  • Review: Known, Emerging, and Remerging Pharyngitis Pathogens (2024) DOI
  • Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers (2024) DOI
  • SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas (2024) DOI
  • <i>NR3C2</i> microdeletions—an underrecognized cause of pseudohypoaldosteronism type 1A: a case report and literature review (2024) DOI
  • Improving Pediatric Clostridioides difficile Testing Practices: Implementation of a 2-Tier Diagnostic Pathway (2023) DOI
  • SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas (2023) DOI
  • Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced (2023) DOI
  • The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas (2023) DOI
  • SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis (2022) DOI

Grants & Funding

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics